FabiFlu News
)
FabiFlu registers 600 percent jump in sales for the month of April
FabiFlu has topped the list of drugs with maximum sales value by recording Rs 762 crore sales
)
India`s drug regulator had reportedly sent the company a notice on overpricing.
Glenmark also denied making any claims that "favipiravir alone" is effective in treatment of mild-to-moderate COVID-19 patients.
FabiFlu`s price is significantly lower than versions of favipiravir in other countries, the company added.
)
DCGI issued a notice to Glenmark Pharmaceuticals over its alleged "false claims" about the use of anti-viral FabiFlu on COVID-19 patients with comorbidities.
Also, the "pricing" of the drug is in question after a Member of Parliament complained about the same.
Loading...
